Dish of the day
Trellus Health (TRLS.L) which is commercialising a scientifically validated, resilience-based, connected health solution for chronic condition management has joined AIM. · Successful Fundraising for gross proceeds of £28.5 million. Market capitalisation of approximately £64.6 million on Admission.
Belluscura has joined AIM (BELL.L). The designer and manufacturer of FDA cleared, lightweight and portable oxygen concentrators has raised gross proceeds of £17.5 million, at an Issue ....
.png)
